# Landiolol in Mitral Valve Surgery

> **NCT06793670** · PHASE4 · RECRUITING · sponsor: **Università Vita-Salute San Raffaele** · enrollment: 1500 (estimated)

## Conditions studied

- Cardiac Failure
- Low Cardiac Output Syndrome

## Interventions

- **DRUG:** Landiolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06793670
- **Lead sponsor:** Università Vita-Salute San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-28
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06793670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06793670, "Landiolol in Mitral Valve Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06793670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*